Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex.
AbbVie Inc. ABBV shares are down during Friday’s premarket session following a Complete Response Letter (CRL) from the FDA ...
OpenAI unveiled on Wednesday ChatGPT for Clinicians, a version of ChatGPT designed to support clinical tasks like ...
Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, today announced that it will release financial results for the first quarter ended March 31, 2026 after the close of trading on ...
Severe non-communicable diseases (NCDs) such as type 1 diabetes mellitus (T1DM), sickle cell disease (SCD), thalassaemia and ...
The MarketWatch News Department was not involved in the creation of this content.-- Proceeds from the financing will support the advancement of three first- and best-in-class ADC ...
Galera Therapeutics, Inc. (“Galera”) (OTC: GRTX), a clinical-stage biopharmaceutical company focused on advancing a pan-NOS inhibitor through clinical development for patients with the ...
New SOL-1 post-hoc analyses presented at VBS reinforce AXPAXLI’s unmatched durability in wet AMD with sustained disease control. AXPAXLI demonstrated robust CSFT control with a ...
New SOL-1 post-hoc analyses presented at VBS reinforce AXPAXLI's unmatched durability in wet AMD with sustained disease control AXPAXLI demonstrated robust CSFT control with a median time of 39 weeks ...
Plan to resume enrollment in clinical study of lorigerlimab in gynecologic cancers • On track to provide mid-2026 program update ROCKVILLE, ...
BENGALURU, India & BRIDGEWATER, N.J.-- (BUSINESS WIRE)--Apr 7, 2026-- ...
A machine learning model that analyzes patient demographics, electronic health record data, and routine blood test results predicted a patient's risk of hepatocellular carcinoma (HCC), the most common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results